期刊
WORLD JOURNAL OF SURGERY
卷 29, 期 3, 页码 276-280出版社
SPRINGER
DOI: 10.1007/s00268-004-7812-7
关键词
-
类别
资金
- NCI NIH HHS [K08 CA85822, R13 CA101889] Funding Source: Medline
- NHLBI NIH HHS [R01 HL65916, R01 HL72716, R01 HL60135, R01 HL61943] Funding Source: Medline
- NIAID NIH HHS [R21 AI 49116] Funding Source: Medline
- NIBIB NIH HHS [R01 EB-002436] Funding Source: Medline
- NIDCR NIH HHS [R10 DE 015543] Funding Source: Medline
Cyclophilins are originally identified as cellular binding proteins for the inummosuppressive drug cyclosporin A. Many cyclophilins, including CypA, CypB, CypC, CypD, and Cyp40, have been discovered and shown to be ubiquitously distributed in many types of cells and organ systems. Recent investigations have uncovered many important properties and functions for cyclophilins including peptidyle-prolyl-isomerase activity and protein folding/repair; maintaining mitochondrial functions and involvement in apoptosis; roles in regulation of T-cell function and inflammation; interaction with CD147; and pathogenesis of vascular disease, human immunodeficiency virus infection, and rheumatoid arthritis. Furthermore, the expression and functions of cyclophilins may be correlated with tumor biology of several types of cancers including pancreatic carcinoma. Molecular mechanisms of cyclophilin-mediated biologic events and future directions of research are discussed in this review. Understanding the roles of cyclophilins in cancers and other organ systems will be crucial in determining clinical applications for the treatment or diagnosis of human diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据